关注
Umesh Kathar
Umesh Kathar
Research Associate at Sai Life Sciences Ltd Hyderabad ll MS (Pharmaceutics) NIPER-Ahm
在 sailife.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Nanomedicine in the treatment of diabetic nephropathy
N Desai, HP Koppisetti, S Pande, H Shukla, B Sirsat, AS Ditani, ...
Future medicinal chemistry 13 (07), 663-686, 2021
152021
Emerging Roles and Biopharmaceutical Applications of Milk Derived Exosomes
RKT Nimeet Desai, Anuradha Gadeval, Umesh Kathar, Pinaki Sengupta, Kiran Kalia
Journal of Drug Delivery Science and Technology, 2021
132021
Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke
M Choudhary, S Chaudhari, T Gupta, D Kalyane, B Sirsat, U Kathar, ...
Pharmaceutics 15 (4), 1036, 2023
22023
Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke. Pharmaceutics 2023, 15, 1036
M Choudhary, S Chaudhari, T Gupta, D Kalyane, B Sirsat, U Kathar, ...
2023
Positron emission tomography as a noninvasive tool in pharmacokinetic studies
V Tambe, U Kathar, N Raval, K Rajpoot, S Shilpi, K Khatri, RK Tekade
Biopharmaceutics and Pharmacokinetics Considerations, 617-641, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–5